NCT06891131 Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock
| NCT ID | NCT06891131 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Haemorrhagic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2025-06-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will evaluate the implementation of a treatment bundle (Fibrinogen, Plasma and Tranexamic Acid)
Eligibility Criteria
Inclusion Criteria: * aged, or believed to be aged * 18 years or above * confirmed or suspected life-threatening bleeding from trauma (i.e. signs of inadequate perfusion of tissues, tachycardia, hypotension, suspected blood loss) * need for volume replacement therapy. Exclusion Criteria: * patient with known recent history of thromboembolic events within the last 6 months * known or suspected pregnancy at presentation * patient with known refusal of a participation in this clinical trial.
Contact & Investigator
Gabriel Honnef, MD, PhD
PRINCIPAL INVESTIGATOR
Medical University of Graz, Department of Anaesthesiology
Frequently Asked Questions
Who can join the NCT06891131 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Haemorrhagic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06891131 currently recruiting?
Yes, NCT06891131 is actively recruiting participants. Contact the research team at gabriel.honnef@medunigraz.at for enrollment information.
Where is the NCT06891131 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT06891131 clinical trial?
NCT06891131 is sponsored by Medical University of Graz. The principal investigator is Gabriel Honnef, MD, PhD at Medical University of Graz, Department of Anaesthesiology. The trial plans to enroll 10 participants.